title: Parvovirus B19-induced type II mixed cryoglobulinemia.
authors.forename: Audrey
authors.initials: A
authors.lastname: Gorse
authors.forename: Julien
authors.initials: J
authors.lastname: Boileau
authors.forename: Joëlle
authors.initials: J
authors.lastname: Goetz
authors.forename: Françoise
authors.initials: F
authors.lastname: Stoll-Keller
authors.forename: Thierry
authors.initials: T
authors.lastname: Martin
mesh_terms: D000208:Acute Disease; D000914:Antibodies, Viral / Q000097:blood; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003449:Cryoglobulinemia / Q000175:diagnosis* / Q000188:drug therapy / Q000821:virology; D004279:DNA, Viral / Q000032:analysis; D003937:Diagnosis, Differential; D015432:Glomerulonephritis, Membranoproliferative / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D010322:Parvoviridae Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000821:virology; D016732:Parvovirus B19, Human / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D019562:Viral Load; D014774:Virulence
chemical_list: D000914:Antibodies, Viral; D000970:Antineoplastic Agents; D004279:DNA, Viral; D013792:Thalidomide; D000077269:Lenalidomide